GAPDHP14

Across TCGA pan-cancer cohorts, GAPDHP14 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated GAPDHP14 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher GAPDHP14 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GAPDHP14 expression acts as an unfavorable survival marker, although some lineages such as SKCM and OV show a favorable association.

BRCA, ACC, and KIRC are the cancer types where GAPDHP14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	III,IV	0.293	0.651	.001	69	view →
ACC	OS	Quartile	All	0.304	0.718	<.001	46	view →
KIRC	OS	Tertile	All	0.539	0.685	.002	42	view →
LGG	DFS	Quartile	All	0.630	0.781	<.001	33	view →
THCA	OS	Tertile	IV	0.444	0.871	.001	24	view →
SKCM	OS	Median	All	0.372	0.249	.002	19	view →
OV	OS	Quartile	IV	0.785	0.425	.005	18	view →
KICH	DFS	Tertile	III,IV	0.269	0.865	.014	15	view →
LUAD	OS	Quartile	All	0.591	0.735	.006	14	view →
KIRP	DFS	Quartile	III,IV	0.851	0.543	.045	7	view →
LAML	DFS	Quartile	All	0.567	0.154	.009	6	view →
UCS	DFS	Quartile	II,III,IV	0.522	0.130	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

GAPDHP14–BRCA (OS)

Open the BRCA breakdown →